Literature DB >> 6222774

Evaluation of the circulating and splenic lymphocyte subpopulations in patients with non-Hodgkin lymphomas and Hodgkin's disease using monoclonal antibodies.

F Herrmann, G Sieber, B Jauer, A Lochner, B Komischke, H Rühl.   

Abstract

The number of B lymphocytes, T lymphocytes and their helper/inducer, cytotoxic/suppressor and NK/K subpopulations was measured in peripheral blood and spleen cell suspensions from patients with Hodgkin's disease (HD) in the active stage of the disease and in remission status, as well as in Non-Hodgkin lymphomas (NHL) in active stage of the disease. B lymphocytes were determined by direct immunofluorescence and T lymphocytes with the E rosette technique. Helper/inducer, cytotoxic/suppressor, and NK/K T lymphocytes were determined by indirect immunofluorescence with the monoclonal antibodies OKT4, OKT8 and Leu 7 (HNK1). In the same way, Lyt3 was used for determination of the total T lymphocytes. Whereas in peripheral blood of the NHL group an increase of B lymphocytes and a slight reduction of T lymphocytes could be observed, with normal distribution of the subpopulations, in patients with active HD as well as in those in remission, a marked absolute and relative decrease of T helper/inducer cells was found with normal cytotoxic/suppressor and NK/K proportion. In contrast to this, a significant increase of helper/inducer T lymphocytes with decreased cytotoxic/suppressor T proportion was found in spleen cell suspensions of patients with HD.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222774     DOI: 10.1007/bf00321049

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  35 in total

1.  Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.

Authors:  Z Fuks; S Strober; D P King; H S Kaplan
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

2.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

3.  Immune alterations in patients with Hodgkin's disease.

Authors:  H Rühl; U Rühl; G Sieber
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1979

4.  Altered proportion of T mu-and T gamma-cell subpopulations in patients with Hodgkin's disease.

Authors:  S Romagnani; E Maggi; R Biagiotti; M G Giudizi; A Amadori; M Ricci
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

Review 5.  Malignant disease of the lymphoid system in immunological perspective.

Authors:  J A Hansen; R A Good
Journal:  Hum Pathol       Date:  1974-09       Impact factor: 3.466

6.  Blastogenic responses of lymphocytes from patients with untreated and treated lymphomas.

Authors:  E M Hersh; W S Irvin
Journal:  Lymphology       Date:  1969-12       Impact factor: 1.286

7.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

8.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Characteristics of immunoglobulin secretion in man evaluated by a reverse hemolytic plaque assay.

Authors:  G Sieber; G Bochert; B Enders; H Rühl
Journal:  Blut       Date:  1980-08

10.  Human lymphocyte traffic assessed by indium-111 oxine labelling: clinical observations.

Authors:  J Wagstaff; C Gibson; N Thatcher; W L Ford; H Sharma; D Crowther
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more
  3 in total

Review 1.  Distribution of lymphocyte subsets and natural killer cells in the human body.

Authors:  J Westermann; R Pabst
Journal:  Clin Investig       Date:  1992-07

2.  Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.

Authors:  R Mukhopadhyaya; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

3.  Cyclophosphamide decreases O6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation.

Authors:  S M Lee; D Crowther; J H Scarffe; M Dougal; R H Elder; J A Rafferty; G P Margison
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.